Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist®)-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre

[1]  Dow-Mu Koh,et al.  The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  Michael Laniado,et al.  Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions , 2008, European Radiology.

[3]  M. Fried,et al.  Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG‐PET‐CT , 2008, Journal of clinical ultrasound : JCU.

[4]  N. Jamieson,et al.  F18-FDG-PET evaluation of patients for resection of colorectal liver metastases. , 2007, Hepato-gastroenterology.

[5]  E. Leen,et al.  Radiological staging of colorectal liver metastases. , 2007, Surgical oncology.

[6]  A. Loft,et al.  Contrast-enhanced FDG-PET/CT vs. spio-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation , 2007, Acta radiologica.

[7]  Emily V M Ward,et al.  FDG PET in preoperative assessment of colorectal liver metastases combining "evidence-based practice" and "technology assessment" methods to develop departmental imaging protocols: should FDG PET be routinely used in the preoperative assessment of patients with colorectal liver metastases? , 2007, Academic radiology.

[8]  A. Figer,et al.  The Role and Limitations of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography (FDG-PET) Scan and Computerized Tomography (CT) in Restaging Patients with Hepatic Colorectal Metastases Following Neoadjuvant Chemotherapy: Comparison with Operative and Pathological Findings , 2007, Journal of Gastrointestinal Surgery.

[9]  M. Choti,et al.  Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases. , 2006, Archives of surgery.

[10]  M. Langer,et al.  Detection and characterization of benign focal liver lesions with multislice CT , 2006, European Radiology.

[11]  Sukru Mehmet Erturk,et al.  PET imaging for evaluation of metastatic colorectal cancer of the liver. , 2006, European journal of radiology.

[12]  O. Belohlávek,et al.  The role of FDG-PET/CT in the detection of recurrent colorectal cancer , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  O. Garden,et al.  Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies , 2006, British Journal of Cancer.

[14]  W. Oyen,et al.  The impact of fluor‐18‐deoxyglucose‐positron emission tomography in the management of colorectal liver metastases , 2005, Cancer.

[15]  S. Larson,et al.  Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Wolfgang Schima,et al.  Liver metastases of colorectal cancer: US, CT or MR? , 2005, Cancer imaging : the official publication of the International Cancer Imaging Society.

[17]  Janice Ward,et al.  Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. , 2005, Radiology.

[18]  A. Zwinderman,et al.  Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. , 2005, Radiology.

[19]  Osman Ratib,et al.  Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  E. Rummeny,et al.  Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging , 2005, European Radiology.

[21]  Young Kon Kim,et al.  Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging , 2005, European Radiology.

[22]  P. Clavien,et al.  Does the Novel PET/CT Imaging Modality Impact on the Treatment of Patients With Metastatic Colorectal Cancer of the Liver? , 2004, Annals of surgery.

[23]  B. Davidson,et al.  Prospective study of contrast‐enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging colorectal liver metastases for liver resection , 2004, The British journal of surgery.

[24]  E. Fishman,et al.  Incremental value of CT in PET/CT of patients with colorectal carcinoma , 2004, Abdominal Imaging.

[25]  S. Park,et al.  Small (, 2004, AJR. American journal of roentgenology.

[26]  D. Visvikis,et al.  FDG-PET for the pre-operative evaluation of colorectal liver metastases. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  M. Caterino,et al.  Evaluation of hepatic metastases from colorectal carcinoma with MR-superparamagnetic iron oxide. , 2004, Journal of experimental & clinical cancer research : CR.

[28]  R. Wahl,et al.  Direct Comparison of 18F-FDG PET and PET/CT in Patients with Colorectal Carcinoma , 2003 .

[29]  Janice Ward,et al.  Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging--comparison of optimized sequences. , 2003, Radiology.

[30]  Joon Seok Lim,et al.  Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. , 2003, Radiology.

[31]  K. Hirata,et al.  Efficacy of SPIO-MR Imaging in the Diagnosis of Liver Metastases from Colorectal Carcinomas , 2003, Digestive Surgery.

[32]  Y. Amano,et al.  Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging , 2003, Abdominal Radiology.

[33]  T. Vogl,et al.  Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US , 2003, European Radiology.

[34]  P. J. Robinson,et al.  The early detection of liver metastases , 2002, Cancer Imaging.

[35]  T. Ichikawa,et al.  Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver. , 2002, Radiology.

[36]  Ying Lu,et al.  Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. , 2002, Radiology.

[37]  M. Oudkerk,et al.  Ferumoxide-enhanced magnetic resonance imaging techniques in pre-operative assessment for colorectal liver metastases. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[38]  W. Schima,et al.  Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. , 2002, AJR. American journal of roentgenology.

[39]  T. Ruers,et al.  Treatment of liver metastases, an update on the possibilities and results. , 2002, European journal of cancer.

[40]  Jan Grimm,et al.  Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. , 2002, Radiology.

[41]  W. Oyen,et al.  Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  V. Komborozos,et al.  The Contribution of Follow-Up Programs in the Reduction of Mortality of Rectal Cancer Recurrences , 2001, Digestive Surgery.

[43]  G. Coates,et al.  Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.

[44]  M. Kanematsu,et al.  Detection of malignant hepatic tumors: comparison of gadolinium-and ferumoxide-enhanced MR imaging. , 2001, AJR. American journal of roentgenology.

[45]  L. Wagman,et al.  Clinical and Cost Effectiveness of a New Hepatocellular MRI Contrast Agent, Mangafodipir Trisodium, in the Preoperative Assessment of Liver Resectability , 2001, Annals of Surgical Oncology.

[46]  S S Gambhir,et al.  A tabulated summary of the FDG PET literature. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[47]  T. John,et al.  Current status of surgery in colorectal metastases to the liver. , 2001, Hepato-gastroenterology.

[48]  D. Wilson,et al.  Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings. , 2001, Clinical radiology.

[49]  R. Semelka,et al.  Focal liver lesions: Comparison of dual‐phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement , 2001, Journal of magnetic resonance imaging : JMRI.

[50]  L. Mortelmans,et al.  Clinical value of whole-body positron emission tomography in potentially curable colorectal liver metastases☆ , 2001 .

[51]  B. Ulrich,et al.  Costs and efficiency of a tumor follow-up program for the detection of colorectal liver metastases , 2001, International Journal of Colorectal Disease.

[52]  J. Lodge.  Modern surgery for liver metastases. , 2000, Cancer imaging : the official publication of the International Cancer Imaging Society.

[53]  C. Marx,et al.  Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. , 2000, Radiology.

[54]  P. Boyle,et al.  ABC of colorectal cancer: Epidemiology , 2000, BMJ.

[55]  P. Simmonds,et al.  Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis , 2000, BMJ : British Medical Journal.

[56]  Paul Kinahan,et al.  A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[57]  G. Marchal,et al.  Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study. , 2000, Radiology.

[58]  P. Robinson,et al.  MRI of liver: a comparison of CNR enhancement using high dose and low dose ferumoxide infusion in patients with colorectal liver metastases. , 2000, Magnetic resonance imaging.

[59]  T. Murakami,et al.  Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. , 2000, AJR. American journal of roentgenology.

[60]  P. Ros,et al.  CT and MR imaging of hepatic metastases. , 2000, AJR. American journal of roentgenology.

[61]  S. Saini,et al.  Addition of gadolinium chelates to heavily T2-weighted MR imaging: limited role in differentiating hepatic hemangiomas from metastases. , 2000, AJR. American journal of roentgenology.

[62]  J. Barkhausen,et al.  Spio-MR Imaging versus Double-Phase Spiral CT in Detecting Malignant Lesions of the Liver , 1999, Acta radiologica.

[63]  M Georgi,et al.  MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesions. , 1999, Magnetic resonance imaging.

[64]  P. Robinson,et al.  Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. , 1999, Radiology.

[65]  A. Lacy,et al.  Value of postoperative surveillance after radical surgery for colorectal cancer , 1998, Diseases of the colon and rectum.

[66]  J. Figueras,et al.  Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma. , 1998, AJR. American journal of roentgenology.

[67]  J. Fleshman,et al.  Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography , 1997, Annals of Surgical Oncology.

[68]  R. Semelka,et al.  Liver lesion detection, characterization, and effect on patient management: Comparison of single‐phase spiral CT and current MR techniques , 1997, Journal of magnetic resonance imaging : JMRI.

[69]  E. Rummeny,et al.  MnDPDP for MR imaging of the liver , 1997, Acta radiologica.

[70]  P. Robinson,et al.  Hepatic lesion detection at MR imaging: a comparative study with four sequences. , 1997, Radiology.

[71]  M Oudkerk,et al.  Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. , 1997, Radiology.

[72]  M. Taupitz,et al.  Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? , 1997, Radiology.

[73]  B. V. Van Beers,et al.  Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging. , 1997, AJR. American journal of roentgenology.

[74]  T. Murakami,et al.  Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. , 1996, Radiology.

[75]  B. V. Van Beers,et al.  Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. , 1996, Radiology.

[76]  M. Mack,et al.  Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. , 1996, Radiology.

[77]  M. Fulham,et al.  The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. , 1996, Archives of surgery.

[78]  M Takahashi,et al.  Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. , 1996, Radiology.

[79]  G. Morana,et al.  Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application. , 1996, Radiology.

[80]  E. Rummeny,et al.  Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. , 1996, Radiology.

[81]  T. Murakami,et al.  Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma. , 1996, AJR. American journal of roentgenology.

[82]  S. Curley,et al.  Improved survival after resection of colorectal liver metastases , 1995, Annals of Surgical Oncology.

[83]  B. Marincek,et al.  Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. , 1995, Radiology.

[84]  S E Seltzer,et al.  Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. , 1995, Radiology.

[85]  M. Taupitz,et al.  Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. , 1995, Radiology.

[86]  A. Altendorf-Hofmann,et al.  Factors influencing the natural history of colorectal liver metastases , 1994, The Lancet.

[87]  R. Semelka,et al.  Solitary hepatic metastasis: Comparison of dynamic contrast‐enhanced CT and MR imaging with fat‐suppressed T2‐weighted, Breath‐hold T1‐weighted FLASH, and dynamic gadolinium‐enhanced FLASH sequences , 1994, Journal of magnetic resonance imaging : JMRI.

[88]  R. Jeffrey,et al.  Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. , 1993, Radiology.

[89]  F. Safi,et al.  Is follow-up of colorectal cancer patients worthwhile? , 1993, Diseases of the colon and rectum.

[90]  A. Altendorf-Hofmann,et al.  Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history , 1990, The British journal of surgery.

[91]  H. Goldberg,et al.  Comparison of computed tomography and magnetic resonance imaging in the evaluation of focal hepatic lesions , 1990, Gastrointestinal Radiology.

[92]  P Schmidlin,et al.  Recurrence of colorectal tumors: PET evaluation. , 1989, Radiology.

[93]  R C Nelson,et al.  Liver and abdominal screening in patients with cancer: CT versus MR imaging. , 1988, Radiology.

[94]  C. Bartolozzi,et al.  Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT , 2004, European Radiology.

[95]  E. Martin,et al.  Positron Emission Tomography Affects Surgical Management in Recurrent Colorectal Cancer Patients , 2003, Annals of Surgical Oncology.

[96]  R. Wahl,et al.  Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[97]  J. Figueras,et al.  Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. , 2001, Radiology.

[98]  L. Mortelmans,et al.  Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[99]  H. Zirngibl,et al.  Intraoperative Ultrasonography versus Helical Computed Tomography and Computed Tomography with Arterioportography in Diagnosing Colorectal Liver Metastases: Lesion-by-lesion Analysis , 2000, World Journal of Surgery.

[100]  S DeSena,et al.  Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT. , 2000, AJR. American journal of roentgenology.

[101]  M V Knopp,et al.  Hepatic lesions: morphologic and functional characterization with multiphase breath-hold 3D gadolinium-enhanced MR angiography--initial results. , 1999, Radiology.

[102]  M. Choti,et al.  Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings. , 1996, AJR. American journal of roentgenology.

[103]  H. Stettner,et al.  Hepatic resection for metastases from colorectal carcinoma--a survival analysis. , 1995, European journal of cancer.

[104]  C. Metz,et al.  Detection of Hepatic Metastases: Comparisonof Contrast-Enhanced CT, Unenhanced MR Imaging, and Iron Oxide- , 1990 .

[105]  M. Koretz.  Hepatic resection for metastatic colorectal cancer. , 1988, Journal of the Medical Association of Georgia.

[106]  Atul Wad,et al.  Technology assessment , 1984 .